Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

Flovent HFA, GSK’s brand name for its discontinued ... Alternate medications, such as Asmanex and Symbicort, are either in short supply or more difficult to get covered by insurers.

inhalation aerosol - Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol The AAN has applauded these ...